Author profile
Miami Cancer Institute - BHSF
This study compares brain dose metrics evaluated using multiple dedicated stereotactic radiosurgery (SRS) delivery platforms for the treatment of brain metastases.
To evaluate patient-specific quality assurance (PSQA) measurements across 18 disease sites treated with intensity modulated proton therapy (IMPT) from January 2024 through August 2025.
Occupational exposure during Lutetium-177 (Lu-177) radiopharmaceutical therapy depends on administration technique, shielding configuration, and staff proximity—temporal and spatial. This study quantified extremity and whole-body exposure contributions for va...
To experimentally quantify the mechanical delivery errors of a pre-clinical Dynamical Collimation System (DCS) prototype for intensity modulated proton therapy (IMPT) and evaluate the dosimetric impact of these errors to the target coverage and organ sparing.
Recent Phase 3 trial literature provides evidence for IMPT as the standard-of-care treatment for oropharyngeal cancer. Proton dynamic arc therapy (DynamicArc) potentially offers further refinement of IMPT. The goal of this work was to compare DynamicArc versu...
This study presents dosimetric results for stereotactic radiosurgery (SRS) using a self-shielded gyroscopic radiosurgery system for meningioma patients.
Efficacy, feasibility, and safety of extracranial, single-fraction MR-guided adaptive radiotherapy (SMART-1fx) was reported in the SMART ONE trial (NCT04939246). This work evaluates SMART plan quality relative to RTOG-0813 standards for an expanded cohort.
Stereotactic radiosurgery (SRS) plan optimization requires balancing high-quality dosimetry and treatment efficiency. This study compares treatment plan quality between the recently launched Zap-Axon optimizer and the Leksell Gamma Knife (GK) Lightning optimi...